EFFICACY OF PIRFENIDONE ON DYSPNEA IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): RESULTS FROM A POST HOC RESPONDER ANALYSIS

被引：0
|
作者：
Glassberg, Marilyn K.
Thavarajah, Krishna
Collins, Bridget F.
Gupta, Sachin
Trzaskoma, Benjamin
Kirchgaessler, Klaus-Uwe
Devine, Jacob
Raghu, Ganesh
机构：
来源：
CHEST | 2022年 / 162卷 / 04期
关键词：
D O I：
10.1016/j.chest.2022.08.996
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1246A / 1247A
页数：2
相关论文
共 50 条
  • [41] Antiacid Therapy And Disease Progression In Patients With Idiopathic Pulmonary Fibrosis (ipf) Under Pirfenidone Treatment
    Kreuter, M.
    Spagnolo, P.
    Wuyts, W.
    Renzoni, E.
    Koschel, D.
    Maher, T. M.
    Kolb, M.
    Weycker, D.
    Kirchgaessler, K. -U.
    Costabel, U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [42] THE PHARMACOKINETICS OF BIBF 1120 ALONE OR IN COMBINATION WITH PIRFENIDONE IN JAPANESE PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Inoue, Y.
    Azuma, A.
    Taniguchi, H.
    Ogura, T.
    Tadayasu, Y.
    Fujimoto, T.
    Klueglich, M.
    Sugiyama, Y.
    Nukiwa, T.
    RESPIROLOGY, 2011, 16 : 318 - 318
  • [43] Molecular Modulation of Treatment Response of Idiopathic Pulmonary Fibrosis (IPF) Patients Following Pirfenidone Therapy
    O'Callaghan, G.
    Khan, K. A.
    McCarthy, Y.
    Houston, A. M.
    Subramaniam, A.
    Elshafi, M.
    Bourke, L.
    Plant, B. J.
    Henry, M. T.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S523 - S524
  • [44] Serum surfactant protein D as a predictive biomarker for the efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of the phase 3 trial in Japan
    Ikeda, Kimiyuki
    Chiba, Hirofumi
    Nishikiori, Hirotaka
    Azuma, Arata
    Kondoh, Yasuhiro
    Ogura, Takashi
    Taguchi, Yoshio
    Ebina, Masahito
    Sakaguchi, Hiroki
    Miyazawa, Shogo
    Suga, Moritaka
    Sugiyama, Yukihiko
    Nukiwa, Toshihiro
    Kudoh, Shoji
    Takahashi, Hiroki
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [45] Serum surfactant protein D as a predictive biomarker for the efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of the phase 3 trial in Japan
    Kimiyuki Ikeda
    Hirofumi Chiba
    Hirotaka Nishikiori
    Arata Azuma
    Yasuhiro Kondoh
    Takashi Ogura
    Yoshio Taguchi
    Masahito Ebina
    Hiroki Sakaguchi
    Shogo Miyazawa
    Moritaka Suga
    Yukihiko Sugiyama
    Toshihiro Nukiwa
    Shoji Kudoh
    Hiroki Takahashi
    Respiratory Research, 21
  • [46] CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis
    Iwasawa, Tae
    Ogura, Takashi
    Sakai, Fumikazu
    Kanauchi, Tetsu
    Komagata, Takanobu
    Baba, Tomohisa
    Gotoh, Toshiyuki
    Morita, Satoshi
    Yazawa, Takuya
    Inoue, Tomio
    EUROPEAN JOURNAL OF RADIOLOGY, 2014, 83 (01) : 32 - 38
  • [47] Analysis and review of patients with idiopathic pulmonary fibrosis treated with pirfenidone
    Valle Corpas, Margarita
    Casas Hidalgo, Inmaculada
    Rodriguez Delgado, Alejandro
    Moreno Raya, Patricia
    Moron Romero, Rocio
    Gonzalez Medina, Maria del Carmen
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 333 - 334
  • [48] Safety and efficacy of pirfenidone in severe idiopathic pulmonary fibrosis
    Ntolios, Paschalis
    Koulelidis, Andreas
    Zacharis, Georgios
    Tzouvelekis, Argyrios
    Boglou, Panagiotis
    Kaltsas, Konstantinos
    Bouros, Evangelos
    Karampitsakos, Theodoros
    Karailidou, Maria
    Steiropoulos, Paschalis
    Froudarakis, Manes
    Bouros, Demosthenes
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [49] Efficacy and Safety of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis
    Yoon, Hee-Young
    Kim, Dong Soon
    Song, Jin Woo
    RESPIRATION, 2019, 97 (03) : 242 - 251
  • [50] Pirfenidone in idiopathic pulmonary fibrosis (IPF): Early single centre Irish experience
    Barry, Peter
    Murphy, Lorna
    Tuohy, Majella
    Judge, Eoin
    Egan, Jim
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
12345